ILLUMINA INC (ILMN)

US4523271090 - Common Stock

132.35  -0.95 (-0.71%)

After market: 132.35 0 (0%)

News Image
20 hours ago - Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

News Image
10 days ago - Chartmill

These S&P500 stocks are moving in today's session

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

News Image
10 days ago - Myriad Genetics, Inc.

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test

News Image
15 days ago - CNBC

Cramer's Lightning Round: Yes to St. Joe

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

News Image
17 days ago - Market News Video

Nasdaq 100 Movers: ILMN, INTC

News Image
18 days ago - Market News Video

Illumina is Now Oversold (ILMN)

News Image
20 days ago - The Motley Fool

Is the Worst Over for Illumina Stock?

There's reason to believe that the future is starting to look better.

News Image
21 days ago - Zacks Investment Research

Illumina (ILMN) Down 14.2% Since Last Earnings Report: Can It Rebound?

Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

News Image
21 days ago - The Motley Fool

Cathie Wood's Buying These 3 Stocks Hand Over Fist

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

News Image
22 days ago - CNBC

Carl Icahn says new Illumina CEO has his 'full support' months after proxy fight

Activist investor Icahn's blessing is a relief for the company as it tries to rebound from a bitter proxy fight with the billionaire investor. 

News Image
22 days ago - Seeking Alpha

Carl Icahn says new Illumina CEO has his 'full support' (NASDAQ:ILMN)

Illumina investor Carl Icahn said Wednesday via X that the company’s incoming CEO, Jacob Thaysen, has his “full support.” Read more here.

News Image
23 days ago - Yahoo Finance

PRESS DIGEST- Financial Times - Sept. 6

The European Commission has appointed Belgium's Didier Reynders as the EU's competition chief, while incumbent commissioner Margrethe Vestager takes a leave of absence to run for the top job at the European Investment Bank. - Illumina has appointed Jacob Thaysen as its new chief executive, as the biotech group seeks to rebuild its leadership team following a bruising battle with activist investor Carl Icahn.

News Image
24 days ago - CNBC

Illumina names new CEO months after Icahn proxy fight over Grail deal

The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza voluntarily stepping down.

News Image
24 days ago - Market News Video

Nasdaq 100 Movers: ILMN, ABNB

News Image
24 days ago - Seeking Alpha

Illumina names Agilent executive as new CEO (NASDAQ:ILMN)

Illumina (ILMN) said Tuesday that Jacob Thaysen, president of Agilent Technologies' (A) Life Sciences and Applied Markets Group, will be its next CEO. Read more here.

News Image
24 days ago - Marketwatch

: Illumina names Agilent executive as new CEO

Illumina Inc. on Tuesday announced that its board has appointed Agilent Technologies Inc. senior vice president Jacob Thaysen as its new CEO, effective Sept....

News Image
24 days ago - Reuters

Illumina names Agilent exec Jacob Thaysen as CEO

U.S. genetic testing company Illumina Inc said on Tuesday its board had named Agilent Technologies' executive Jacob Thaysen as the company's CEO.

News Image
24 days ago - Illumina, Inc.

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has...

News Image
a month ago - Market News Video

S&P 500 Movers: WBD, ILMN

News Image
a month ago - Seeking Alpha

Illumina stock in Evercore’s Tactical Outperform list

Read why Evercore ISI added Illumina, Inc. (ILMN) to the broker's Tactical Outperform list. Read more here.

News Image
a month ago - Marketwatch

: At Illumina, new leadership could fuel turnaround, analysts say

Illumina Inc. shares may be poised for a turnaround as the company hunts for a new CEO, Evercore ISI analysts wrote in a research note Friday. The analysts...

News Image
a month ago - Illumina, Inc.

Illumina To Webcast Upcoming Investor Conference

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st...